Eye-Opening study: which anesthesia reversal drug is safer for your eyes?
NCT ID NCT07666984
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs—sugammadex and neostigmine—used to reverse muscle relaxation after surgery. Researchers will measure the optic nerve sheath diameter (the nerve behind the eye) using ultrasound at key times during recovery. The goal is to see if one drug causes less swelling or pressure on the eye nerve. The trial involves 86 healthy adults undergoing planned surgery, randomly assigned to receive one of the two drugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sugammadex and Neostigmine (with Atropine)
- What this could lead to
- If successful, this study could help anesthesiologists choose the safer drug to reverse muscle relaxation, potentially reducing eye pressure risks during recovery.
- What could go wrong
- This is a small, early-phase study focused on a temporary measurement (optic nerve sheath diameter) rather than long-term outcomes. Results may not apply to all patients or surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROMUSCULAR BLOCKADE REVERSAL AGENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cukurova University Faculty of Medicine
RECRUITINGAdana, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.